Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05925569 · ClinicalTrials.gov registry record · NA
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
A NA study of Hypertension and Resistant Hypertension, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- NA
- Development phase
- 12,501
- Enrollment target
- 1
- Study location
NCT05925569 is a NA study of Hypertension and Resistant Hypertension that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 12,501 participants, above the 3,481-participant average among 470 other Hypertension trials with a reported enrollment target (259% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05925569, a NA study of Hypertension and Resistant Hypertension, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12,501 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary aldosteronism (PA) is common but rarely recognized cause of hypertension that carries excess cardiovascular and renal risk and has approved targeted treatments. Despite current clinical guidelines that recommend screening in a defined set of high-risk populations, less than 5% of eligible patients are ever screened for PA. This study aims to evaluate the impact of a computer decision support Best Practice Advisory (BPA) alert on rates of screening for PA in guideline-eligible patients, referral to specialist PA care, and treatment with mineralocorticoid receptor antagonists.
Conditions Studied
Interventions
- OTHER Best Practice Advisory Computerized Alert
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,501 participants |
| Start Date | 2024-03-13 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05925569
The ClinicalTrials.gov registry entry for NCT05925569 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12,501 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,481-participant average among 470 other Hypertension trials with a reported enrollment target (259% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Best Practice Advisory Computerized Alert is the first listed.
NCT05925569 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05925569 about?
NCT05925569 is a clinical study titled "Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension". Primary aldosteronism (PA) is common but rarely recognized cause of hypertension that carries excess cardiovascular and renal risk and has approved targeted treatments. Despite current clinical guidelines that recommend screening in a defined set of high-risk populations, less than 5% of eligible pa...
What is the current status of trial NCT05925569?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12,501 participants. The study started on 2024-03-13. Estimated completion is 2029-12-31.
What conditions does trial NCT05925569 study?
This clinical trial studies the following conditions: Hypertension, Resistant Hypertension, Primary Aldosteronism, Hyperaldosteronism, Mineralocorticoid Excess.
What interventions are being tested in trial NCT05925569?
The interventions under investigation include: Best Practice Advisory Computerized Alert (OTHER).
Who is sponsoring clinical trial NCT05925569?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05925569 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.